Webcast Alert: InSite Vision Inc. Announces Its Third Quarter Fiscal Year 2006 Financial Results Webcast.ALAMEDA, Calif. -- InSite Vision Inc. (AMEX AMEX See: American Stock Exchange : ISV (Independent Software Vendor) A person or company that develops software. It implies an organization that specializes in software only and is not part of a computer systems or hardware manufacturer. ) announces the following Webcast:
What: InSite Vision Inc. Third Quarter Fiscal Year 2006 Financial
Results Webcast
When: November 14, 2006 @ 09:00 AM Eastern
Where: www.insitevision.com or
http://www.investorcalendar.com/EventPage.asp?ID=111203
How: Live over the Internet -- Simply log on to the web at the
address above.
Contact: Investor Contact
Ashton Partners
Barry Hutton
888-857-7839
www.ashtonpartners.com
If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=111203 or http://www.investorcalendar.com/. InSite Vision is an ophthalmic products company focused on glaucoma glaucoma (glôkō`mə), ocular disorder characterized by pressure within the eyeball caused by an excessive amount of aqueous humor (the fluid substance filling the eyeball). , ocular ocular /oc·u·lar/ (ok´u-lar) 1. of, pertaining to, or affecting the eye. 2. eyepiece. oc·u·lar adj. 1. Of or relating to the eye or the sense of sight. infections and retinal diseases. In the area of glaucoma, the Company conducts genomic research using TIGR TIGR The Institute for Genomic Research TIGR Treasury Investment Growth Receipt TIGR This Is Getting Ridiculous TIGR Thermally Induced Gallium Removal TIGR TSPI Interface for GPS/RAJPO and other genes. A portion of this research has been incorporated into the Company's OcuGene(TM) glaucoma genetic test for disease management, as well as ISV-205, its novel glaucoma therapeutic. In December 2002, InSite Vision reached an agreement with SIFI SIFI Science Fiction (less common than SciFi) SIFI Seismic Induced Frame Instability S.p.A, a leading Italian ophthalmic pharmaceutical company, for them to be the exclusive manufacturer, distributor and promoter of OcuGene in Italy. ISV-205 uses InSite Vision's proprietary DuraSite[R] drug-delivery technology, which also is incorporated into the ocular infection products ISV-401 and ISV-403, and InSite Vision's retinal disease program. Additional company information can be found at www.insitevision.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion